CyMedica Orthopedics receives FDA 510(k) clearance for muscle activation device for knee rehabilitation

CyMedica Orthopedics announced it has received FDA 510(k) clearance for e-vive — an application-controlled, data-driven muscle activation therapy and patient engagement solution for at-home pre-habilitation and rehabilitation muscle strengthening for patients undergoing ACL surgery and total knee replacement.

According to a company press release, e-vive is a wireless muscle stimulation device that addresses issues associated with muscle atrophy. The e-vive application features garment senor technology that transmits key points of data to a secure portal for providers to track patient progress and patient-reported measures to provide more predictable, cost-effective results.

“CyMedica is committed to supporting value-based care by improving the standard of care for ACL and [total knee arthroplasty] TKA rehabilitation patients. With the launch of e-vive, CyMedica is ideally positioned to partner with health care providers looking to improve outcomes, reduce costs and enhance patient satisfaction,” Rob Morocco, president and chief executive officer, said in the release.

Reference: